Although monotherapy with pemetrexed, cisplatin, or anti-PD-L1 antibody all showed significant tumor growth inhibition in the LL2 mouse lung tumor model, the combined treatment of pemetrexed and anti-PD-L1 antibody exerted far more superior tumor suppressive effects (figure 3G). The gene discussed is CD274; the disease is neoplasm.